Elsevier

Foot and Ankle Clinics

Volume 10, Issue 4, December 2005, Pages 651-665
Foot and Ankle Clinics

Mesenchymal Stem Cells for Bone Repair: Preclinical Studies and Potential Orthopedic Applications

https://doi.org/10.1016/j.fcl.2005.06.004Get rights and content

Section snippets

Mesenchymal stem cell isolation and expansion

MSCs are typically isolated from a small bone marrow aspirate obtained from the iliac crest in humans and large animals [11], [19], [20]. In small animals, marrow is typically isolated from the mid-diaphysis of the femur or tibia. Although MSCs are found at a frequency of approximately 1/100,000 nucleated cells in bone marrow [8], MSCs can be isolated and expanded with high efficiency, typically by using standard cell culture techniques, which results in multiple therapeutic doses from one

Characterization of adult mesenchymal stem cells

MSCs have a characteristic immunophenotype and have specific cell surface markers: SH-2, 3, and 4 [8], [14], [21]. The SH-2 antibody reacts with an epitope present on transforming growth factor-beta receptor endoglin (CD105) [22]. SH-3 and SH-4 antibodies recognize distinct epitopes on the membrane bound ecto-5′-nucleotidase (CD73) [14], [23], [24]. Antibodies for SH-2, SH-3, and SH-4 do not react with hematopoietic cells or with osteocytes. SB-10 antigen was also identified as being present on

Critically sized femoral defects

The rat femoral gap model was established and optimized by Stevenson, Einhorn and others [3], [32], [33]. This model is a critically sized segmental defect, typically 8 mm long, that makes it possible to investigate bone repair of cell-loaded implants in an orthotopic site, by using either immunocompromised or immunocompetent animals.

In the first experiment, bone marrow from Fischer 344 rats was used to isolate and expand mesenchymal stem cells for syngeneic implantation [15]. At the end of the

Allogeneic mesenchymal stem cells without the use of immunosuppressive therapy

Providing an autologous MSC construct clinically requires acquisition of a diagnostic bone marrow aspirate from the patient, several weeks for cell expansion and quality control testing, and then implantation back into the patient. The utility of such an approach is limited since there would be a delay of perhaps 1-2 months in providing treatment to the patient. Culture preparation per patient upon request also increases costs and in turn, cost to the patient. An alternative approach would be

Other approaches using mesenchymal stem cells for bone repair

We have discussed animal models that use a ceramic scaffold, namely HA/TCP, as a substrate for MSC induced bone formation for long bone repair. However, for clinical situations requiring bone grafting, such as in the long bone, these ceramics may have unsuitable mechanical properties, exhibiting brittle behavior, and slow resorption rates. The combination of the fracturing of the implant during repair, which results in micromotion, and the ceramic remaining in the defect may impede bone

Summary

Mesenchymal stem cell-based bone regeneration has been demonstrated in various animal models. Preclinical models described in this review primarily focused on the repair of segmental defects. Other orthopedic applications, such as spine fusion and craniotomy defects, are also of interest for the delivery of MSCs. Although preclinical and clinical data for other applications demonstrate safety and efficacy of MSCs, many issues still surround the mechanism of action. Concerns exist regarding the

First page preview

First page preview
Click to open first page preview

References (51)

  • A. Bartholomew et al.

    Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

    Exp Hematol

    (2002)
  • M. DiNicola et al.

    Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non specific mitogenic stimuli

    Blood

    (2002)
  • S. Aggarwal et al.

    Human mesenchymal stem cells modulate allogeneic immune cell responses

    Blood

    (2005)
  • W.E. Braun

    The alloimmunized patient: monitoring and therapeutics

    Am J Med Sci

    (1997)
  • A. Gazdag et al.

    Alternatives to autogenous bone graft: efficacy and indications

    J Am Acad Orthop Surg

    (1995)
  • X. Li et al.

    Differential pattern of incorporation and remodeling among various types of bone grafts

    Acta Anat (Basel)

    (1991)
  • D. Ehrler et al.

    The use of allograft bone in lumbar spine surgery

    Clin Orthop

    (2000)
  • A. Aho et al.

    Incorporation and clinical results of large allograft of the extremities and pelvis

    Clin Orthop

    (1994)
  • M.F. Pittenger et al.

    Multilineage potential of adult human mesenchymal stem cells

    Science

    (1999)
  • A.I. Caplan et al.

    Mesenchymal stem cells and tissue repair

  • N. Jaiswal et al.

    Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro

    J Cell Biochem

    (1997)
  • A. Friedenstein et al.

    Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers

    Cell Tissue Kinet

    (1987)
  • D.P. Lennon et al.

    Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation

    In Vitro Cell Dev Biol Anim

    (1996)
  • J.N. Beresford

    Osteogenic stem cells and the stromal system of bone and marrow

    Clin Orthop

    (1989)
  • S. Haynesworth et al.

    Cell surface antigens on human marrow-derived mesenchymal stem cells are detected by monoclonal antibodies

    J Cell Physiol

    (1992)
  • Cited by (90)

    • <sup>99m</sup>Tc-polyphosphonate labelling – Enhancement of a novel method for the quantification of osteogenic differentiation of MSCs in vitro

      2022, Injury
      Citation Excerpt :

      Usually the in vitro osteogenic potential is accessed by determining the expression of specific proteins and enzymes like alkaline phosphatase [37]. For clinical scientists in the field of bone tissue engineering it is most important to determine directly the mineral deposition (hydroxyapatite) as it is essential for osteogenic regeneration [38,39]. Up to now, the qualitative and quantitative alizarin red staining is the gold standard for the evaluation of osteogenic cell cultures [12].

    • MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway

      2021, Journal of Pharmacological Sciences
      Citation Excerpt :

      Disruption of the normal homeostasis may lead to the decline of bone mass and induce the development of OP.19,20 hMSCs are characterized by abundant sources, strong differentiation potential and easy access, and the mechanisms underlying hMSC osteoblastic differentiation have become a hot topic in bone-related research.21 MicroRNAs (miRNAs) are small non-coding RNAs with approximately 22 nucleotides in length.

    View all citing articles on Scopus
    View full text